CA2086608A1 - Method and apparatus to detect bacterial contamination of transfusable blood - Google Patents
Method and apparatus to detect bacterial contamination of transfusable bloodInfo
- Publication number
- CA2086608A1 CA2086608A1 CA 2086608 CA2086608A CA2086608A1 CA 2086608 A1 CA2086608 A1 CA 2086608A1 CA 2086608 CA2086608 CA 2086608 CA 2086608 A CA2086608 A CA 2086608A CA 2086608 A1 CA2086608 A1 CA 2086608A1
- Authority
- CA
- Canada
- Prior art keywords
- bag
- sensor
- microbial growth
- blood
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 57
- 239000008280 blood Substances 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 27
- 230000001580 bacterial effect Effects 0.000 title claims description 14
- 238000011109 contamination Methods 0.000 title abstract description 8
- 230000000813 microbial effect Effects 0.000 claims abstract description 21
- 210000001124 body fluid Anatomy 0.000 claims abstract description 12
- 239000001963 growth medium Substances 0.000 claims abstract description 9
- 238000012544 monitoring process Methods 0.000 claims abstract description 7
- 238000002835 absorbance Methods 0.000 claims description 52
- 239000000975 dye Substances 0.000 claims description 38
- 230000008859 change Effects 0.000 claims description 26
- 239000011159 matrix material Substances 0.000 claims description 24
- 244000005700 microbiome Species 0.000 claims description 23
- 238000012360 testing method Methods 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 10
- 239000007850 fluorescent dye Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 description 35
- 229920001296 polysiloxane Polymers 0.000 description 22
- 238000009640 blood culture Methods 0.000 description 18
- MGUKYHHAGPFJMC-UHFFFAOYSA-N 4-[3-(4-hydroxy-2,5-dimethylphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-2,5-dimethylphenol Chemical compound C1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C)C=2)C)=C1C MGUKYHHAGPFJMC-UHFFFAOYSA-N 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 238000003556 assay Methods 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 11
- 229920004482 WACKER® Polymers 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000013459 approach Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 6
- 229940043267 rhodamine b Drugs 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- -1 aminobenzoyl group Chemical group 0.000 description 4
- NUHCTOLBWMJMLX-UHFFFAOYSA-N bromothymol blue Chemical compound BrC1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=C(Br)C(O)=C(C(C)C)C=2)C)=C1C NUHCTOLBWMJMLX-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- MUSLHCJRTRQOSP-UHFFFAOYSA-N rhodamine 101 Chemical compound [O-]C(=O)C1=CC=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MUSLHCJRTRQOSP-UHFFFAOYSA-N 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000009827 uniform distribution Methods 0.000 description 4
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003283 colorimetric indicator Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000013047 polymeric layer Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- 108090000915 Aminopeptidases Proteins 0.000 description 2
- 102000004400 Aminopeptidases Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 241000607447 Yersinia enterocolitica Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000007799 cork Substances 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003269 fluorescent indicator Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940098232 yersinia enterocolitica Drugs 0.000 description 2
- PCNMALATRPXTKX-UHFFFAOYSA-N 1,4-dimethylcyclohexa-2,4-dien-1-ol Chemical compound CC1=CCC(C)(O)C=C1 PCNMALATRPXTKX-UHFFFAOYSA-N 0.000 description 1
- CJAOGUFAAWZWNI-UHFFFAOYSA-N 1-n,1-n,4-n,4-n-tetramethylbenzene-1,4-diamine Chemical compound CN(C)C1=CC=C(N(C)C)C=C1 CJAOGUFAAWZWNI-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- RSTKLPZEZYGQPY-UHFFFAOYSA-N 3-(indol-3-yl)pyruvic acid Chemical compound C1=CC=C2C(CC(=O)C(=O)O)=CNC2=C1 RSTKLPZEZYGQPY-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 102000001921 Aminopeptidase P Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 1
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 108010038900 X-Pro aminopeptidase Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000014155 detection of activity Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 238000007421 fluorometric assay Methods 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 150000003739 xylenols Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The present invention relates to a growth monitoring apparatus for collected transfusable bodily fluids. In particular the apparatus involves a flexible blood collection bag (20) or a sample bag (20) containing microbial growth media. A sensor (22) attached to the inside wall of the bag (20) is used to noninvasively detect microbial contamination within the bag (20). This invention also relates to a method to detect microbial growth in a blood collection bag (20) immediately prior to transfusion.
Description
WOs2/lg7~ PCT/US92tO3637 1~
f~
- 2C~8~ )8 z ME~HOD AND APPARATUS TO DETECT BACTERIAL
CONTAMINATION OF TRANSFUSABLE BLOOD
This is a continuation-in-part of U.S. Patent Application Serial No. 07/638,481, filed January 4, 1991; which is in turn a continuation-in-part of U.S.
Patent Application Serial No. 07/609,278, filed November 5, 1990.
Field of the Invention This invention relates to a noninvasive method and apparatus to detect the presence or determine the concentration of microorganisms in a container of transfusable blood prior to transfusion.
Back~round of the Invention Microorganisms present in bodily fluid can be detected using a culture bottle. Generally, a culture bottle is a flask allowing positive cultures to be detected rapidly. The flask is generally a transparent closed container filled with nutrient that promotes the growth of the organism. In particular, bacteria in blood can be detected in culture. U.S.
Patent No. 4,772,559!.-(Hammann).
Many different qualitative and quantitative detection means are used to monitor the growth of microorganisms in a culture bottle. The ~- 25 microorganisms in a culture bottle have been detected by use of external detectors such as a magnifying lens, U.S. Patent No. 4,543,907 (Freudlich).
. ~ , i ~:
~:, .~, , .
.
.
. ' ' :' .
. .~ , . - , . , .. . ..... . . . ..
~:-, , : . ' - : , :. ' .. : : :
WO92/197~ PCT/US92/03637 ~3r` ~ 2 Additionally, internal detectors such as liquid level indicators can show bacterial growth as a function of increased pressure in the vessel Swaine et al., EPA
124,193. Additionally, microorganisms can be detected by measuring changes in pH caused by bacterial growth, Mariel, G.B. Patent No. 1,601,689.
Still another method to detect microorganisms involves the use of a culture media that contains a compound which changes color or appearance according to the growth of microorganisms. The change in the media can be detected with a spectrophotometer. There are many examples of reactions used in Microbiology that rely on a color change. Bascomb, Enzvme Tests in Bacterial Identification, Meth. Microbiol. 19, 105 (1987). For example, a variety of organisms can be classified in large part by their pattern of fermentation, oxidation or assimilation of carbon sources. Fermentation of carbohydrates results in the production of acid which causes a decrease in pH.
This drop in pH can be easily detected by including a pH indicator like bromthymol blue or phenol red. With both indicators, acid conditions representing the fermentation of a particular carbohydrate result in a yellow color (changing from blue-green for bromthymol 25 ,blue or pink/red for phenol red). The same approach can be adopted for a variety of carbohydrates, ranging from monosaccharides like glucose to polysaccharides ` like inulin. In an analogous fashion, increasing pH
can be also be monitored. Assays for detecting the , .~ .
.,~ .
:'.: . :
;.,. :. . . , :
.~,: : ~ .. :
`: ~ ,... . ..
W092/197~ f ! ~ ~ " ' US92/03637 f 3 2~6~8 presence of decarboxylase and urease, and the ability to use malonate are based on an increase in pH, as indicated by a color change in the indicator. Turner, et al. U.S. Patent No. 4,945,060 discloses a device S for detecting microorganisms. In this device changes in the indicator medium resulting from pH changes in C2 concentration in the medium are detected from outside the vessel.
Chemical and enzymatic reactions are used to detect or quantitate the presence of certain substances in microbiological or other assays. Many of these tests rely on the development or change of color or fluorescence to indicate the presence or quantity of the substance of interest.
lS Another approach to determine if an organism can degrade a particular substrate, is to use a reagent which is capable of reacting with one or more of the intermediates or final products. For example, the detection of the reduction of nitrate to nitrite.
If nitrite is formed, then a pink to deep red color ; will result when sulfanilic acid and alpha-naphthylamine are added to the reaction mixture.
; In contrast to the indirect detection of an ~ enzymatic reaction illustrated by the nitrate/nitrite ,test, it is possible to use a,synthetic analog of a natural substrate to directly indicate the presence of an enzyme. For example, methylene blue can be reduced under certain conditions by the action of reductase, resulting in a shift from blue to colorless. In another test, the oxidase assay relies on the interaction of cytochrome oxidase with N, N, N', N'-tetramethyl-p-phenylene-diamine producing a blue color.
: ' -. :
.
W O 92/19764 2~866~8 P ~ /US92/03637 ~ 4 ;`~
, " ; ,~
Another example is the ability of microorganisms to degrade sulfur-containing amino acids as indicated by the production of H2S.
Typically, the organism is incubated with a high concentration of a sulfur-containing substrate (e.g.
cysteine, cystine) in an acid environment. The production of H2S is indicated by the formation of a black precipitate in the presence of ferric ammonium citrate.
Enzymes can usually act on more than one substrate. This allows for the use of synthetic enzyme substrates for the detection of enzyme activities. Synthetic substrates contain a metabolic moiety conjugated with a chromatic or fluorescent moiety. The conjugated molecule usually has a different absorption and/or emission spectrum from the unconjugated form. Moreover, the unconjugated chromatic or fluorescent moiety shows a considerably higher absorption or fluorescence coefficients than those of the conjugated molecule. This allows the measurement of small amounts of products of enzyme activities in the presence of the large amounts of conjugated substrate required for maximal enzyme ;~ ~ activity. An example of a synthetic enzyme substrate ~ -,is o-nitro-phenol-~-galactopyranoside used for the detection of activity of the enzyme ~-galactosidase.
The conjugated substrate is colorless. The ~-galactosidase enzyme hydrolyzes the substrate to yield ~-galactosidase and o-nitro-phenol.
o-nitro-phenol absorbs strongly at 405nm, and its release can be measured by the increase in absorbance ~: at that wavelength. Bascomb, Enzvme Tests in `~ Bacterial Identification, Meth. Microbiol. 19, 105 (1987), reviewed the synthetic moieties used for .; -.:
;;
:
.,;; .
: ; , . . . : ~ : ;
::
:
:;..
WOgZ/l9~ PCT/US92/03637 2~`,B5~6~8 enzyme substrates and the enzymatic activities measurable using this principle.
Presently, the monitoring of color or color end-product in chemical and microbial reactions is usually achieved in either of two ways; 1) the detection of color or color end~product can be achieved by visual observation and estimated qualitatively, or 2) the detection of color end-products or loss of color can be achieved by measuring the intensity of color instrumentally.
Spectrophotometers that measure light absorbance are commonly used for this purpose. When measuring the concehtration of a number of substances it is advantageous to use one instrument based on one principle of measurement, otherwise cost is increased.
Although the use of colorimetric reactions is widespread there are limitations, especially in the sensitivity of detection. In order to improve sensitivity and, in the case of identification of microorganisms, thereby to decrease the time required to obtain a result, fluorescence-based methods frequently are used. Unfortunately, it may not be possible to develop a fluorescent equivalent to every ~ assay. Additionally, the fluorescent reagents ~ --~ 25 ,themselves may be highly toxic and therefore difficult to commercialize.
In such cases one might need to measure activities of some enzymes fluorometrically, the others colorimetrically However, most instruments are suited to measure either absorbance or fluorescence, and very few can be used to measure both.
The general principle of fluorescence quenching has been accepted as a way to detect or : deeermine enzymatic or cherical reactions. Por :
' , , : : ~: . ' , : : : ' - :
~.:; .: .
':. . ~ ', : .
: . ~ ., ; .
W092/197~ PCT/US92/U3637 2~ 6r6p8 .. 6 .. .~ ~ _ example, Fleminger et al. synthesized intramolecularly quenched fluorogenic substrates for the assay of bacterial aminopeptidase, P. Fleminger et al., Fluoroaenic Substrates for Bacterial Aminopeptidase P
and its Analoqs Detected in Human Serum and Calf Luna, Eur. J. Biochem. 125, 609 (1982). In this case, the fluorescence of the aminobenzoyl group is quenched by the presence of a nitrophenylalanyl group. When the enzyme is present, the nitrophenylalanyl group is cleaved, with a concomitant increase in the sample's fluorescence. A variety of enzymes have been assayed by this type of procedure, including hydrolytic enzymes, other amino- and carboxypeptidases and an endopeptidase. Yaron et al., Intramolecularly Ouenched Fluoroaenic Substrates for Hydrolytic Enzvmes, Anal. Biochem. 95, 229 (1979); Carmel et al., IntramolecularlY - Ouenched Fluorescent Peptides as Fluoroaenic Substrates of Leucine Aminopeptidase and Inhibitors of Clostridial Amino~eptidase, Eur. J.
Biochem. 73, 617 (1977); Carmel et al., An Intramolecularlv Ouenched Fluorescent Tri~e~tide as a Fluoroqenic Substrate of Anaiotensin-I-Convertina Enzvme and of Bacterial DipeptidYl Carboxv~eptidase, ~ Eur. J. Biochem. 87, 265 (1978); Florentin et al., _ ,Hiahlv Sensitive Fluorometric Assay for "EnkeDhalinase". a Neutral Metalloendo~eptidase that Releases Tyrosine-GlYcine-Glvcine from Enkephalins, Anal. Biochem. 141, 62 (1984). In each of the previous approaches, a synthetic substrate containing a quenching group and a fluorescing group was generated in order to detect the activity of the enzyme.
, .
,. -. :
- ~:
~ ~ 7 2~s`6~8 An alternatlve to this approach would involve the synthesis of a resonance energy transfer pair of fluorescing groups on a substrate molecule. In this method, cleavage by the enzyme of one of the groups would result in a decrease in fluorescence, since the critical distance would be exceeded, eliminating the transfer of energy. However, the previously discussed approaches are limited to specifically designed substrates.
Still another approach involves the estimation of a chromophore by fluorescence - measurement. See W. Blumberg et al., Hemoqlobin Determined in Whole Blood "Front Face" Fluorometry, Clin. Hemo. 26, 409 (1980). Blumberg disclosed an assay based on attenuation of fluorescence of a dye, whose excitation wavelengths overlap with the absorption wavelengths of the chromophore.
Subsequently, M. Shaffer, U.S. Patent No.
4,495,293 (hereinafter Shaffer) filed a patent application disclosing a method to fluorometrically determine a ligand in an assay solution using conventional fluorometric techniques. In Shaffer the intensity of the fluorescence emitted by the assay ~ solution is related to the change in transmissive ,properties of the assay solution produced by the interac7tion of the ligand to be determined and a reagent system capable of producing change in the transmissive properties of the assay solution in the presence of the ligand. More particularly, Shaffer discloses a method to monitor absorbance using a fluorophore in solution with the chromophore. In this method the fluorophore may interact with the assay cocktail and produce changes in fluorescence intensity which are unrelated to the change being measured. The - .:
, .` : . . ~
WO 92/19764 PCI`/US92/03637.
3S~8 8 ~ r selection of the fluorophores is also restricted, in that pH dependent or environment sensitive fluorophores cannot be utilized. Additionally, when the fluorophore is in solution, less than accurate measure of absorbance may be obtained because light is - absorbed exponentially through the chromophore sample.
Similarly, Beggs & Sand, EPA 91,837 disclosed a solution based method for determination of tryptophan-deaminase activity by measuring the reduction in fluorescence in the presence of a chromophore produced by the interaction between indole pyruvic acid and metal ions using a fluorophore "whose fluorescence is capable of being quenched by the indole pyruvate-metal ion complex, the ions of the fluorophore being present throughout the incubation period".
Also, Sands, U.S. Patent No. 4,798,788 discloses a process to detect a nitrate reducing microorganism by measuring reduction of fluorescence in solution by causing the diazotization of the fluorophore. In all these cases a specific fluorophore needs to be chosen for each test to ensure that it will fluoresce under the conditions of the ; ~ tèst, e.g. only few fluorophores fluoresce at pH of 2S ,less than 2Ø
In addition to blood culture tests, a need exists to develop a noninvasive means to determine bacterial contamination of blood in a collection bag immediately prior to transfusion. Although, the previously discussed blood culture test can be used to determine bacterial contamination of transfusable blood, these test may result in errors. First, the transfusion bag must be later matched with a separate blood culture bottle sent to a test center to make a .:
. .
....... . . .. . . ~ . .
. . . . . - : .
'' ~" ' `~ . - . ' ~
.
: . . , ~ : -.,, :
- ~ . . . .
~"'i I
9 ,,Z~,~S,6,~;
determination of potential microbial contamination prior to transfusion of the blood. This requirement for subsequent matching could result in errors.
Additionally, blood culture bottles are cultured at higher temperature than the temperature that blood is normally stored; as such blood culture bottle tests yield an accelerated picture of bacterial contamination, while a test that simulates actual blood storage conditions may yield more accurate results.
.
Summarv of the Invention This invention relates to a multi-layer body fluid culture sensor comprised of a pH sensitive absorbance based dye spectrally coupled to a pH
insensitive, or pH sensitive dye that is highly buffered, fluorescence based dye. The pH sensitive absorbance based dye is encapsulated ar isolated in a polymeric layer that is permeable to CO2 and water, but impermeable to protons. The pH insensitive fluorophore is encapsulated or isolated in the second polymeric layer that may or may not be permeable to C2 and water. This type of sensor may be used to detect or determine the concentration of ,microorganisms in bodily fluid. The spectral criterion required to make this determination are such ~ that the absorption spectrum of the chromophore must -` overlap the excitation and/or emission spectrum of the fluorophore, thereby allowing the change in fluorescence to be related to the change in the reaction and consequently related to the presence or quantity of the substance of interest.
Further, this sensor is used to monitor microbial growth in collected transfusable blood. In :"; ' .
:' .
, .
i '~.. . - . ` : ` . ;.''~ ' '', ' .. . . . .
: . . , . : ' , ': :
i.. ~:. !
f~
- 2C~8~ )8 z ME~HOD AND APPARATUS TO DETECT BACTERIAL
CONTAMINATION OF TRANSFUSABLE BLOOD
This is a continuation-in-part of U.S. Patent Application Serial No. 07/638,481, filed January 4, 1991; which is in turn a continuation-in-part of U.S.
Patent Application Serial No. 07/609,278, filed November 5, 1990.
Field of the Invention This invention relates to a noninvasive method and apparatus to detect the presence or determine the concentration of microorganisms in a container of transfusable blood prior to transfusion.
Back~round of the Invention Microorganisms present in bodily fluid can be detected using a culture bottle. Generally, a culture bottle is a flask allowing positive cultures to be detected rapidly. The flask is generally a transparent closed container filled with nutrient that promotes the growth of the organism. In particular, bacteria in blood can be detected in culture. U.S.
Patent No. 4,772,559!.-(Hammann).
Many different qualitative and quantitative detection means are used to monitor the growth of microorganisms in a culture bottle. The ~- 25 microorganisms in a culture bottle have been detected by use of external detectors such as a magnifying lens, U.S. Patent No. 4,543,907 (Freudlich).
. ~ , i ~:
~:, .~, , .
.
.
. ' ' :' .
. .~ , . - , . , .. . ..... . . . ..
~:-, , : . ' - : , :. ' .. : : :
WO92/197~ PCT/US92/03637 ~3r` ~ 2 Additionally, internal detectors such as liquid level indicators can show bacterial growth as a function of increased pressure in the vessel Swaine et al., EPA
124,193. Additionally, microorganisms can be detected by measuring changes in pH caused by bacterial growth, Mariel, G.B. Patent No. 1,601,689.
Still another method to detect microorganisms involves the use of a culture media that contains a compound which changes color or appearance according to the growth of microorganisms. The change in the media can be detected with a spectrophotometer. There are many examples of reactions used in Microbiology that rely on a color change. Bascomb, Enzvme Tests in Bacterial Identification, Meth. Microbiol. 19, 105 (1987). For example, a variety of organisms can be classified in large part by their pattern of fermentation, oxidation or assimilation of carbon sources. Fermentation of carbohydrates results in the production of acid which causes a decrease in pH.
This drop in pH can be easily detected by including a pH indicator like bromthymol blue or phenol red. With both indicators, acid conditions representing the fermentation of a particular carbohydrate result in a yellow color (changing from blue-green for bromthymol 25 ,blue or pink/red for phenol red). The same approach can be adopted for a variety of carbohydrates, ranging from monosaccharides like glucose to polysaccharides ` like inulin. In an analogous fashion, increasing pH
can be also be monitored. Assays for detecting the , .~ .
.,~ .
:'.: . :
;.,. :. . . , :
.~,: : ~ .. :
`: ~ ,... . ..
W092/197~ f ! ~ ~ " ' US92/03637 f 3 2~6~8 presence of decarboxylase and urease, and the ability to use malonate are based on an increase in pH, as indicated by a color change in the indicator. Turner, et al. U.S. Patent No. 4,945,060 discloses a device S for detecting microorganisms. In this device changes in the indicator medium resulting from pH changes in C2 concentration in the medium are detected from outside the vessel.
Chemical and enzymatic reactions are used to detect or quantitate the presence of certain substances in microbiological or other assays. Many of these tests rely on the development or change of color or fluorescence to indicate the presence or quantity of the substance of interest.
lS Another approach to determine if an organism can degrade a particular substrate, is to use a reagent which is capable of reacting with one or more of the intermediates or final products. For example, the detection of the reduction of nitrate to nitrite.
If nitrite is formed, then a pink to deep red color ; will result when sulfanilic acid and alpha-naphthylamine are added to the reaction mixture.
; In contrast to the indirect detection of an ~ enzymatic reaction illustrated by the nitrate/nitrite ,test, it is possible to use a,synthetic analog of a natural substrate to directly indicate the presence of an enzyme. For example, methylene blue can be reduced under certain conditions by the action of reductase, resulting in a shift from blue to colorless. In another test, the oxidase assay relies on the interaction of cytochrome oxidase with N, N, N', N'-tetramethyl-p-phenylene-diamine producing a blue color.
: ' -. :
.
W O 92/19764 2~866~8 P ~ /US92/03637 ~ 4 ;`~
, " ; ,~
Another example is the ability of microorganisms to degrade sulfur-containing amino acids as indicated by the production of H2S.
Typically, the organism is incubated with a high concentration of a sulfur-containing substrate (e.g.
cysteine, cystine) in an acid environment. The production of H2S is indicated by the formation of a black precipitate in the presence of ferric ammonium citrate.
Enzymes can usually act on more than one substrate. This allows for the use of synthetic enzyme substrates for the detection of enzyme activities. Synthetic substrates contain a metabolic moiety conjugated with a chromatic or fluorescent moiety. The conjugated molecule usually has a different absorption and/or emission spectrum from the unconjugated form. Moreover, the unconjugated chromatic or fluorescent moiety shows a considerably higher absorption or fluorescence coefficients than those of the conjugated molecule. This allows the measurement of small amounts of products of enzyme activities in the presence of the large amounts of conjugated substrate required for maximal enzyme ;~ ~ activity. An example of a synthetic enzyme substrate ~ -,is o-nitro-phenol-~-galactopyranoside used for the detection of activity of the enzyme ~-galactosidase.
The conjugated substrate is colorless. The ~-galactosidase enzyme hydrolyzes the substrate to yield ~-galactosidase and o-nitro-phenol.
o-nitro-phenol absorbs strongly at 405nm, and its release can be measured by the increase in absorbance ~: at that wavelength. Bascomb, Enzvme Tests in `~ Bacterial Identification, Meth. Microbiol. 19, 105 (1987), reviewed the synthetic moieties used for .; -.:
;;
:
.,;; .
: ; , . . . : ~ : ;
::
:
:;..
WOgZ/l9~ PCT/US92/03637 2~`,B5~6~8 enzyme substrates and the enzymatic activities measurable using this principle.
Presently, the monitoring of color or color end-product in chemical and microbial reactions is usually achieved in either of two ways; 1) the detection of color or color end~product can be achieved by visual observation and estimated qualitatively, or 2) the detection of color end-products or loss of color can be achieved by measuring the intensity of color instrumentally.
Spectrophotometers that measure light absorbance are commonly used for this purpose. When measuring the concehtration of a number of substances it is advantageous to use one instrument based on one principle of measurement, otherwise cost is increased.
Although the use of colorimetric reactions is widespread there are limitations, especially in the sensitivity of detection. In order to improve sensitivity and, in the case of identification of microorganisms, thereby to decrease the time required to obtain a result, fluorescence-based methods frequently are used. Unfortunately, it may not be possible to develop a fluorescent equivalent to every ~ assay. Additionally, the fluorescent reagents ~ --~ 25 ,themselves may be highly toxic and therefore difficult to commercialize.
In such cases one might need to measure activities of some enzymes fluorometrically, the others colorimetrically However, most instruments are suited to measure either absorbance or fluorescence, and very few can be used to measure both.
The general principle of fluorescence quenching has been accepted as a way to detect or : deeermine enzymatic or cherical reactions. Por :
' , , : : ~: . ' , : : : ' - :
~.:; .: .
':. . ~ ', : .
: . ~ ., ; .
W092/197~ PCT/US92/U3637 2~ 6r6p8 .. 6 .. .~ ~ _ example, Fleminger et al. synthesized intramolecularly quenched fluorogenic substrates for the assay of bacterial aminopeptidase, P. Fleminger et al., Fluoroaenic Substrates for Bacterial Aminopeptidase P
and its Analoqs Detected in Human Serum and Calf Luna, Eur. J. Biochem. 125, 609 (1982). In this case, the fluorescence of the aminobenzoyl group is quenched by the presence of a nitrophenylalanyl group. When the enzyme is present, the nitrophenylalanyl group is cleaved, with a concomitant increase in the sample's fluorescence. A variety of enzymes have been assayed by this type of procedure, including hydrolytic enzymes, other amino- and carboxypeptidases and an endopeptidase. Yaron et al., Intramolecularly Ouenched Fluoroaenic Substrates for Hydrolytic Enzvmes, Anal. Biochem. 95, 229 (1979); Carmel et al., IntramolecularlY - Ouenched Fluorescent Peptides as Fluoroaenic Substrates of Leucine Aminopeptidase and Inhibitors of Clostridial Amino~eptidase, Eur. J.
Biochem. 73, 617 (1977); Carmel et al., An Intramolecularlv Ouenched Fluorescent Tri~e~tide as a Fluoroqenic Substrate of Anaiotensin-I-Convertina Enzvme and of Bacterial DipeptidYl Carboxv~eptidase, ~ Eur. J. Biochem. 87, 265 (1978); Florentin et al., _ ,Hiahlv Sensitive Fluorometric Assay for "EnkeDhalinase". a Neutral Metalloendo~eptidase that Releases Tyrosine-GlYcine-Glvcine from Enkephalins, Anal. Biochem. 141, 62 (1984). In each of the previous approaches, a synthetic substrate containing a quenching group and a fluorescing group was generated in order to detect the activity of the enzyme.
, .
,. -. :
- ~:
~ ~ 7 2~s`6~8 An alternatlve to this approach would involve the synthesis of a resonance energy transfer pair of fluorescing groups on a substrate molecule. In this method, cleavage by the enzyme of one of the groups would result in a decrease in fluorescence, since the critical distance would be exceeded, eliminating the transfer of energy. However, the previously discussed approaches are limited to specifically designed substrates.
Still another approach involves the estimation of a chromophore by fluorescence - measurement. See W. Blumberg et al., Hemoqlobin Determined in Whole Blood "Front Face" Fluorometry, Clin. Hemo. 26, 409 (1980). Blumberg disclosed an assay based on attenuation of fluorescence of a dye, whose excitation wavelengths overlap with the absorption wavelengths of the chromophore.
Subsequently, M. Shaffer, U.S. Patent No.
4,495,293 (hereinafter Shaffer) filed a patent application disclosing a method to fluorometrically determine a ligand in an assay solution using conventional fluorometric techniques. In Shaffer the intensity of the fluorescence emitted by the assay ~ solution is related to the change in transmissive ,properties of the assay solution produced by the interac7tion of the ligand to be determined and a reagent system capable of producing change in the transmissive properties of the assay solution in the presence of the ligand. More particularly, Shaffer discloses a method to monitor absorbance using a fluorophore in solution with the chromophore. In this method the fluorophore may interact with the assay cocktail and produce changes in fluorescence intensity which are unrelated to the change being measured. The - .:
, .` : . . ~
WO 92/19764 PCI`/US92/03637.
3S~8 8 ~ r selection of the fluorophores is also restricted, in that pH dependent or environment sensitive fluorophores cannot be utilized. Additionally, when the fluorophore is in solution, less than accurate measure of absorbance may be obtained because light is - absorbed exponentially through the chromophore sample.
Similarly, Beggs & Sand, EPA 91,837 disclosed a solution based method for determination of tryptophan-deaminase activity by measuring the reduction in fluorescence in the presence of a chromophore produced by the interaction between indole pyruvic acid and metal ions using a fluorophore "whose fluorescence is capable of being quenched by the indole pyruvate-metal ion complex, the ions of the fluorophore being present throughout the incubation period".
Also, Sands, U.S. Patent No. 4,798,788 discloses a process to detect a nitrate reducing microorganism by measuring reduction of fluorescence in solution by causing the diazotization of the fluorophore. In all these cases a specific fluorophore needs to be chosen for each test to ensure that it will fluoresce under the conditions of the ; ~ tèst, e.g. only few fluorophores fluoresce at pH of 2S ,less than 2Ø
In addition to blood culture tests, a need exists to develop a noninvasive means to determine bacterial contamination of blood in a collection bag immediately prior to transfusion. Although, the previously discussed blood culture test can be used to determine bacterial contamination of transfusable blood, these test may result in errors. First, the transfusion bag must be later matched with a separate blood culture bottle sent to a test center to make a .:
. .
....... . . .. . . ~ . .
. . . . . - : .
'' ~" ' `~ . - . ' ~
.
: . . , ~ : -.,, :
- ~ . . . .
~"'i I
9 ,,Z~,~S,6,~;
determination of potential microbial contamination prior to transfusion of the blood. This requirement for subsequent matching could result in errors.
Additionally, blood culture bottles are cultured at higher temperature than the temperature that blood is normally stored; as such blood culture bottle tests yield an accelerated picture of bacterial contamination, while a test that simulates actual blood storage conditions may yield more accurate results.
.
Summarv of the Invention This invention relates to a multi-layer body fluid culture sensor comprised of a pH sensitive absorbance based dye spectrally coupled to a pH
insensitive, or pH sensitive dye that is highly buffered, fluorescence based dye. The pH sensitive absorbance based dye is encapsulated ar isolated in a polymeric layer that is permeable to CO2 and water, but impermeable to protons. The pH insensitive fluorophore is encapsulated or isolated in the second polymeric layer that may or may not be permeable to C2 and water. This type of sensor may be used to detect or determine the concentration of ,microorganisms in bodily fluid. The spectral criterion required to make this determination are such ~ that the absorption spectrum of the chromophore must -` overlap the excitation and/or emission spectrum of the fluorophore, thereby allowing the change in fluorescence to be related to the change in the reaction and consequently related to the presence or quantity of the substance of interest.
Further, this sensor is used to monitor microbial growth in collected transfusable blood. In :"; ' .
:' .
, .
i '~.. . - . ` : ` . ;.''~ ' '', ' .. . . . .
: . . , . : ' , ': :
i.. ~:. !
3~'~8 10 l'.''';
particular, this sensor can be used to monitor bacterial growth in a collection bag of bodily fluid that is to be transfused into a patient. As bacteria grow they generate CO2. The CO2 generated by the bacteria diffuses into the polymeric layer that is in direct contact with a hydrated pH sensitive absorbance based dye. The CO2 reacts with the aqueous environment to form carbonic acid (H2CO3), which lowers the pH of the absorbance dye environment.- This results in a concomitant chanqe in the pH sensitive spectrum of the dye. Typically, as the absorbance of an absorbance based dye decreases more light reaches the fluorophore for excitation which results in a larger amount of emitted fluorescence.
The sensor is attached to a blood collection bag or separate sampler test bag. If a separate sampler bag is used this bag may contain microbial growth media or an inert substance such as a saline.
With this system microbial contamination of transfusable blood in a collection bag can be determined immediately prior to transfusion. In one embodiment of this invention a detector, such as a handheld fluorescence detector, is used to monitor the emitted fluorescence.
.~ . .
Brief Description of the Fiaures Fig. 1 shows a schematic diagram of a - multi-layer blood culture sensor.
Fig. 2 shows a blood culture growth curve detected by a xylenol blue-rhodamine 101 sensor.
Fig. 3 shows a blood culture growth curve detected by xylenol blue in silicone-rhodamine B in acrylic sensor.
. .
, .. . . .
, ' , ' .
, ' ' . ': :
. '' '' ~ . .' ~VO92/19764 PCT/US92/03637 .
Fig. 4 shows a blood culture growth curve for a xylenol blue in silicone-6213 acrylic sensor.
Fig. 5 shows a blood culture growth curve for a bromthymol blue in silicone-rhodamine 101 in silicone sensor.
Fig. 6 shows a sample test blood collection bag and fluorescent detector for monitoring growth of microorganisms in blood.
Fig. 7 shows the percent change of fluorescent intensity versus time for two blood samples.
.
Detailed Description - Best Mode In this approach, fluorescence from a fluorophore embedded in an inert light-transparent matrix, is modulated by a pH sensitive absorbance dye embedded in a polymeric gas permeable, but proton impermeable matrix. The assay is carried out in a blood collection bag or sampler test blood collection bag.
In a fluorometric based colorimetric assay the fluorescence intensity is regulated by changes in absorbance of an interfering chromophore. As a pH
change occurs the chromophoric material alters the ,amount of emitted light reaching the fluorophore and/or the amount of emitted light reaching the detector. Spectrally compatible fluorescent and colorimetric indicators are selected so that as the pH
changes due to the production of Co2 by microorganisms present in the blood, the coIorimetric indicators regulate the amount of light reaching the fluorophore and/or photodetector and, thus cause a change in the excitation and/or emission of the - .
:'' "
- , ,, .. ~ . . ~, . . . . . .
: : . . - - ~ , WO92/197~ PCT/US92/03637 ~ 12 fluorescent dye. This change is detected with a fluorescent reader and can be correlated with the presence or concentration of microorganisms in the blood.
A bodily fluid culture sensor is comprised of a pH sensitive absorbance based dye in or isolated by a polymeric gas permeable, but proton impermeable matrix, and a fluorescent dye in a second polymeric matrix.
Spectrally compatible fluorescent and colorimetric indicators are selected so that when an organism is present in blood, the colorimetric indicator will regulate the amount of light reaching the fluorophore thereby causing a change in the emission intensity from the fluorescence dye reaching the photodetector. The change, indicating the presence of bacteria, is detected with a fluorometric reader.
More particularly, spectrally compatible fluorescence and absorbance dyes are selected dyes are selected so that as carbonic acid is produced (CO2 and H2O), the absorbance of the dye will change : thereby regulating the amount of light reaching the ~fluorophore and/or photodetector, thus producing a change in the measured fluorescence. This change is detected with a fluorescence reader. Spectrally compatible dyes are rhodamine B and xylenol blue.
Additionally, bromthymol blue and rhodamine 101 are also spectrally compatible.
For example this can be illustrated by inoculating a bag containing the appropriate growth media with Yersinia enterocolitica. As the organism grows, it produces CO2 gas. The silicone is permeable to the CO2. The CO2 diffuses to the ~ , , ., : , . . .
. - ~ . . ~ .
',` ' ' ' ",, ' ' ~' ' , . .
W092/197~ PCT/US92/03637 13~
absorbance layer and reacts with water to produce carbonic acid (H2C03). The carbonic acid causes a drop in the pH in the absorbance dye environment resulting in a change in measured absorbance. For 5 example, as the pH drops in an absorbance layer containing the dye xylenol blue, the absorbance of xylenol blue decreases, thereby allowing more light to reach the fluorophore to excite it and thus increase the amount of fluorescence emitted at 590nm. A
10 positive culture using xylenol blue as the absorbance ?
dye is detected by increase the amount of fluorescence emitted at 590nm. A positive culture using xylenol blue as the absorbance dye is detected by a measured increase in fluorescence as the xylenol blue decreases 15 in absorbance See Fig. 7.
The pH sensitive absorbance based dye is encapsulated in or isolated by a polymeric matrix that is gas permeable, but proton impermeable. The polymeric matrix must be optically transparent in the 20 visible region, permeable to gas, autoclavable, stable for at least six months, and proton impermeable. In s particular, silicone may function as the polymeric matrix used to encapsulate or isolate the absorbance ~ based dye. Silicones found to meet these criteria 25 ,were Dow, Rhone Poulenc, G.E. and Wacker.
Similarly, the fluorescence based dyes can ; also be encapsulated in a polymeric matrix. The polymeric matrix used for the fluorophore does not have to meet all of the above requirements listed for 30 the matrix used to encapsulate or isolate the absorbance dye. The similar features that it must ~- -possess are that it must be optically transparent in the visible region, autoclavable and stable for at least six months.
: ':
~,..... . . . . .
. i ~ . . . . , ~ .
- , . .. , . . ~ ~ .. - .
, W092/197~ PCT~VS92~03637 ~
~ S6~8 14 ~
The polymeric matrix containing or isolating the absorbance based dye must be coupled to the polymeric matrix containing the fluorescent dye. It should be noted that the polymeric matrices must be in close proximity so that light that has been regulated by the absorbance layer will have an effect on the emission intensity of the fluorophore as received by the photodetector. This can be accomplished by applying the same polymeric material to one side of each polymeric matrix and curing these matrices. Once the matrices containing the dyes have been adhered together they must be rehydrated. The clarity of the sensor upon rehydration is also a factor in matrix selection.
In particular, in the present invention, a microorganism growth monitoring system for collected transfusable blood is shown in Fig. 6. The monitoring system shown in Fig. 6 is comprised of a sampler test blood collection bag 20. A bar code 28 can be attached to the bag to record data for later inspection. Blood from the blood collection bag to be transfused is expressed through tube 24 to sampler ` test blood collection bag 20. The wall of the blood ~ collection bag contains a multi-layer sensor 22 ,comprising a pH sensitive dye in a light transmissive, - gas permeable, proton impermeable matrix and a pH
- insensitive fluorescence dye in inert light transparent matrix, said first and second matrices being spectrally coupled. The blood collection or - 30 blood storage bag can contain whole blood, plasma, serum, erythrocytes, red blood corpuscles, leukocytes, white blood corpuscles, thrombocytes and blood platelets, collectively referred to as blood storage.
`'~
. .
~' ` , ~ :
: . .
:.''. "' . . . .
.
:
. ~ .
WO92/197~ PCT/US92/03637 l .is~ ?.~ 3S6~8 In the present invention the sensor can be located on the interior wall of the blood collection bag or a separate sampler test blood collection bag to which blood can be shunted for assessment. These various types of bags are heretofore collectively referred to as blood collectlon bag.
If a separate blood collection bag is employed the bag may contain a growth media or an inert substance such as saline.
In the present invention the two-layer sensor is mounted inside a blood collection bag such that one layer, of the sensor is positioned facing outside the - bag. The second layer which is fluorescent is positioned facing the interior of the bag. The sensor may be formed integrally with the wall of the bag.
The invention, then, is comprised of the two-layer sensor outlined abovej mounted inside a blood collection container in such a way that by utilizing a fluorometer to excite the fluorescent sensor and detect the emitted fluorescent light, a determination can be made as to the presence of a threshold level of microorganisms contained within the blood collection container.
An additional feature of this invention is i 25, that the bag is stored at normal blood storage temperatures, i.e. 4~C. In this environment certain microorganisms are not affected by the cold: Yersinia enterocolitica and Enterobacter aaalomerans.
Additionally, the system allows for the determination of other bacteria that would not normally grow rapidly in the cold but might be present in such high concentrations over time that it would be unsafe to transfuse into a patient: Citrobacter freundii;
Pseudomonas aeruainosa; Staphvlococcus aureus; and Staphvlococcus e~idermidis.
..... ",.. . . .
:: - . . , ;. . ,. ,, : , , : . . .:
.. ~ . . . . .
. ., : . . : .
:., ,, . . ~. . .
.. . . .
WO92/197~ PCT/US92/03637 2~366~3 An alternative approach would follow the same design but would consist solely of an absorbance sensor. In this case the increase is CO2 produced by the growing microorganisms and subsequent drop in pH would result in a visible color change in the sensor. This change in color visible to the blood handler, or detected by a colorimeter would signal that the blood contained a threshold level of microorganisms.
Another feature of this invention involves covering the sensor with a gas permeable membrane to prevent naturally fluorescing substances in the blood from interacting with the fluorescent measurement.
In and alternative embodiment shown in Fig.
1, a bodily fluid culture sensor, is comprised of a pH
sensitive absorbance based dye encapsulated in or isolated by a polymeric gas permeable, but proton impermeable matrix 4 and a fluorescent dye in a second polymeric matrix 2. Reflectiv~ surface 6 can be included to facilitate the transmission of light to the detecting element 12. In Fig. 1 interrogation light enters the sensor and is regulated by pH
sensitive matrix 2 which in turn causes a change in ~ the fluorescence emission 10 of the fluorophore in - 25 ,matrix 4. This sensor offers the advantage of maximal surface area.
A measurement is taken by first reading reference light intensity. Next the reading from the sensor disk is measured. The data is plotted by taking the ratio of reference, excitation light, to sample. In particular, as CO2 levels increase in the blood collection bag, the absorbance of the absorbance dye changes, thereby changing the amount of light reaching the fluorescence layer and/or photodetector. This causes a change in emitted fluorescence that is detected.
:~' .
, .~ ~ . - . . .
. :. .. , : . ' ' r, ''' ' , " ' ~ ' ., . ' . ~
' ~ ' '' '' ' ~ ' ~
W092/l9764 PCT/US92/03637 ` 17 ` ~ 6~ i The following examples serve to illustrate the method of the present invention. The concentration of reagents and other variable parameters are only shown to exemplify the methods of the present invention and are not to be considered ~ .
limitation thereof.
Example 1 At the time a unit of blood is drawn, an additional amount (lOml) is collected in such a manner as to be subsequently sectioned off from the unit to be transfused. This additional blood is then expressed through a tube into a flexible bag, attached to the blood collection bag. This side bag is supplied containing a microorganism growth media and an attached multi-layer sensor. The sensor is capable of detecting microorganism growth by measuring an increase in CO2 production through a change in fluorescence emitted from the sensor.
After adding the additional blood to the bag containing media and the sensor, and waiting a predetermined amount of time (2 - 6 hours) for the sensor to equilibrate, an initial reading of the sensor is made using a portable handheld fluorometer ` ,to produce a baseline fluorescence level. This level can be ~anually recorded for latter comparison or a bar code can be provided and attached to the bag. The ; blood and additional monitoring bag are then stored in -~ a normal manner (4C).
~- At the time the blood is to be used for `; 30 transfusion a second reading of the sensor is made and compared to the first reading. This is compared to the original reading. If a bar code was produced, the bar code and sensor are read. The instrument will :
.
. .
.` .
.. ^. .. A ....... . . - --.
:.. ' ~ ' ' . . .
,". . ~ ' - :-. - '- ' '':. - . ;
WO92/197~ PCTIUS92/03~37 ` Z~S6~8 18 `;
compare the initial and final fluorescent values and based upon an established threshold level of change will signal negative or positive for growth. In this particular embodiment, the instrument will signal green for no growth or red for growth based on differences in original and final sensor readings.
Exam~le 2 Xylenol Blue - Rhodamine 101 Sensor Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the manufacturer. Next - 5% w/w of a 50mM xylenol blue, dissolved in 5mM borate buffer pH 11 containing 1% Tween 80, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55C for 2 hours.
Wacker silicone is prepared, as described above. Next 2~ w/w of 7.5mM Rhodamine 101, in 50mM
Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone. The mixture is poured over the previously cured xylenol blue layer in the mold, described above, and cured at 55C overnight. This cured, dehydrated, double layer sensor consists of two 25 distinct layers, each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto ~- the base of bottles using more silicone, ensuring that the absorbance layer is face down. Finally, the bottles are cured at 55C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes. Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum. The blood .:; .
,. ~ .
`., ,~
.
.
: : .
..
. .
", ' " ~'~ - . :' : .
particular, this sensor can be used to monitor bacterial growth in a collection bag of bodily fluid that is to be transfused into a patient. As bacteria grow they generate CO2. The CO2 generated by the bacteria diffuses into the polymeric layer that is in direct contact with a hydrated pH sensitive absorbance based dye. The CO2 reacts with the aqueous environment to form carbonic acid (H2CO3), which lowers the pH of the absorbance dye environment.- This results in a concomitant chanqe in the pH sensitive spectrum of the dye. Typically, as the absorbance of an absorbance based dye decreases more light reaches the fluorophore for excitation which results in a larger amount of emitted fluorescence.
The sensor is attached to a blood collection bag or separate sampler test bag. If a separate sampler bag is used this bag may contain microbial growth media or an inert substance such as a saline.
With this system microbial contamination of transfusable blood in a collection bag can be determined immediately prior to transfusion. In one embodiment of this invention a detector, such as a handheld fluorescence detector, is used to monitor the emitted fluorescence.
.~ . .
Brief Description of the Fiaures Fig. 1 shows a schematic diagram of a - multi-layer blood culture sensor.
Fig. 2 shows a blood culture growth curve detected by a xylenol blue-rhodamine 101 sensor.
Fig. 3 shows a blood culture growth curve detected by xylenol blue in silicone-rhodamine B in acrylic sensor.
. .
, .. . . .
, ' , ' .
, ' ' . ': :
. '' '' ~ . .' ~VO92/19764 PCT/US92/03637 .
Fig. 4 shows a blood culture growth curve for a xylenol blue in silicone-6213 acrylic sensor.
Fig. 5 shows a blood culture growth curve for a bromthymol blue in silicone-rhodamine 101 in silicone sensor.
Fig. 6 shows a sample test blood collection bag and fluorescent detector for monitoring growth of microorganisms in blood.
Fig. 7 shows the percent change of fluorescent intensity versus time for two blood samples.
.
Detailed Description - Best Mode In this approach, fluorescence from a fluorophore embedded in an inert light-transparent matrix, is modulated by a pH sensitive absorbance dye embedded in a polymeric gas permeable, but proton impermeable matrix. The assay is carried out in a blood collection bag or sampler test blood collection bag.
In a fluorometric based colorimetric assay the fluorescence intensity is regulated by changes in absorbance of an interfering chromophore. As a pH
change occurs the chromophoric material alters the ,amount of emitted light reaching the fluorophore and/or the amount of emitted light reaching the detector. Spectrally compatible fluorescent and colorimetric indicators are selected so that as the pH
changes due to the production of Co2 by microorganisms present in the blood, the coIorimetric indicators regulate the amount of light reaching the fluorophore and/or photodetector and, thus cause a change in the excitation and/or emission of the - .
:'' "
- , ,, .. ~ . . ~, . . . . . .
: : . . - - ~ , WO92/197~ PCT/US92/03637 ~ 12 fluorescent dye. This change is detected with a fluorescent reader and can be correlated with the presence or concentration of microorganisms in the blood.
A bodily fluid culture sensor is comprised of a pH sensitive absorbance based dye in or isolated by a polymeric gas permeable, but proton impermeable matrix, and a fluorescent dye in a second polymeric matrix.
Spectrally compatible fluorescent and colorimetric indicators are selected so that when an organism is present in blood, the colorimetric indicator will regulate the amount of light reaching the fluorophore thereby causing a change in the emission intensity from the fluorescence dye reaching the photodetector. The change, indicating the presence of bacteria, is detected with a fluorometric reader.
More particularly, spectrally compatible fluorescence and absorbance dyes are selected dyes are selected so that as carbonic acid is produced (CO2 and H2O), the absorbance of the dye will change : thereby regulating the amount of light reaching the ~fluorophore and/or photodetector, thus producing a change in the measured fluorescence. This change is detected with a fluorescence reader. Spectrally compatible dyes are rhodamine B and xylenol blue.
Additionally, bromthymol blue and rhodamine 101 are also spectrally compatible.
For example this can be illustrated by inoculating a bag containing the appropriate growth media with Yersinia enterocolitica. As the organism grows, it produces CO2 gas. The silicone is permeable to the CO2. The CO2 diffuses to the ~ , , ., : , . . .
. - ~ . . ~ .
',` ' ' ' ",, ' ' ~' ' , . .
W092/197~ PCT/US92/03637 13~
absorbance layer and reacts with water to produce carbonic acid (H2C03). The carbonic acid causes a drop in the pH in the absorbance dye environment resulting in a change in measured absorbance. For 5 example, as the pH drops in an absorbance layer containing the dye xylenol blue, the absorbance of xylenol blue decreases, thereby allowing more light to reach the fluorophore to excite it and thus increase the amount of fluorescence emitted at 590nm. A
10 positive culture using xylenol blue as the absorbance ?
dye is detected by increase the amount of fluorescence emitted at 590nm. A positive culture using xylenol blue as the absorbance dye is detected by a measured increase in fluorescence as the xylenol blue decreases 15 in absorbance See Fig. 7.
The pH sensitive absorbance based dye is encapsulated in or isolated by a polymeric matrix that is gas permeable, but proton impermeable. The polymeric matrix must be optically transparent in the 20 visible region, permeable to gas, autoclavable, stable for at least six months, and proton impermeable. In s particular, silicone may function as the polymeric matrix used to encapsulate or isolate the absorbance ~ based dye. Silicones found to meet these criteria 25 ,were Dow, Rhone Poulenc, G.E. and Wacker.
Similarly, the fluorescence based dyes can ; also be encapsulated in a polymeric matrix. The polymeric matrix used for the fluorophore does not have to meet all of the above requirements listed for 30 the matrix used to encapsulate or isolate the absorbance dye. The similar features that it must ~- -possess are that it must be optically transparent in the visible region, autoclavable and stable for at least six months.
: ':
~,..... . . . . .
. i ~ . . . . , ~ .
- , . .. , . . ~ ~ .. - .
, W092/197~ PCT~VS92~03637 ~
~ S6~8 14 ~
The polymeric matrix containing or isolating the absorbance based dye must be coupled to the polymeric matrix containing the fluorescent dye. It should be noted that the polymeric matrices must be in close proximity so that light that has been regulated by the absorbance layer will have an effect on the emission intensity of the fluorophore as received by the photodetector. This can be accomplished by applying the same polymeric material to one side of each polymeric matrix and curing these matrices. Once the matrices containing the dyes have been adhered together they must be rehydrated. The clarity of the sensor upon rehydration is also a factor in matrix selection.
In particular, in the present invention, a microorganism growth monitoring system for collected transfusable blood is shown in Fig. 6. The monitoring system shown in Fig. 6 is comprised of a sampler test blood collection bag 20. A bar code 28 can be attached to the bag to record data for later inspection. Blood from the blood collection bag to be transfused is expressed through tube 24 to sampler ` test blood collection bag 20. The wall of the blood ~ collection bag contains a multi-layer sensor 22 ,comprising a pH sensitive dye in a light transmissive, - gas permeable, proton impermeable matrix and a pH
- insensitive fluorescence dye in inert light transparent matrix, said first and second matrices being spectrally coupled. The blood collection or - 30 blood storage bag can contain whole blood, plasma, serum, erythrocytes, red blood corpuscles, leukocytes, white blood corpuscles, thrombocytes and blood platelets, collectively referred to as blood storage.
`'~
. .
~' ` , ~ :
: . .
:.''. "' . . . .
.
:
. ~ .
WO92/197~ PCT/US92/03637 l .is~ ?.~ 3S6~8 In the present invention the sensor can be located on the interior wall of the blood collection bag or a separate sampler test blood collection bag to which blood can be shunted for assessment. These various types of bags are heretofore collectively referred to as blood collectlon bag.
If a separate blood collection bag is employed the bag may contain a growth media or an inert substance such as saline.
In the present invention the two-layer sensor is mounted inside a blood collection bag such that one layer, of the sensor is positioned facing outside the - bag. The second layer which is fluorescent is positioned facing the interior of the bag. The sensor may be formed integrally with the wall of the bag.
The invention, then, is comprised of the two-layer sensor outlined abovej mounted inside a blood collection container in such a way that by utilizing a fluorometer to excite the fluorescent sensor and detect the emitted fluorescent light, a determination can be made as to the presence of a threshold level of microorganisms contained within the blood collection container.
An additional feature of this invention is i 25, that the bag is stored at normal blood storage temperatures, i.e. 4~C. In this environment certain microorganisms are not affected by the cold: Yersinia enterocolitica and Enterobacter aaalomerans.
Additionally, the system allows for the determination of other bacteria that would not normally grow rapidly in the cold but might be present in such high concentrations over time that it would be unsafe to transfuse into a patient: Citrobacter freundii;
Pseudomonas aeruainosa; Staphvlococcus aureus; and Staphvlococcus e~idermidis.
..... ",.. . . .
:: - . . , ;. . ,. ,, : , , : . . .:
.. ~ . . . . .
. ., : . . : .
:., ,, . . ~. . .
.. . . .
WO92/197~ PCT/US92/03637 2~366~3 An alternative approach would follow the same design but would consist solely of an absorbance sensor. In this case the increase is CO2 produced by the growing microorganisms and subsequent drop in pH would result in a visible color change in the sensor. This change in color visible to the blood handler, or detected by a colorimeter would signal that the blood contained a threshold level of microorganisms.
Another feature of this invention involves covering the sensor with a gas permeable membrane to prevent naturally fluorescing substances in the blood from interacting with the fluorescent measurement.
In and alternative embodiment shown in Fig.
1, a bodily fluid culture sensor, is comprised of a pH
sensitive absorbance based dye encapsulated in or isolated by a polymeric gas permeable, but proton impermeable matrix 4 and a fluorescent dye in a second polymeric matrix 2. Reflectiv~ surface 6 can be included to facilitate the transmission of light to the detecting element 12. In Fig. 1 interrogation light enters the sensor and is regulated by pH
sensitive matrix 2 which in turn causes a change in ~ the fluorescence emission 10 of the fluorophore in - 25 ,matrix 4. This sensor offers the advantage of maximal surface area.
A measurement is taken by first reading reference light intensity. Next the reading from the sensor disk is measured. The data is plotted by taking the ratio of reference, excitation light, to sample. In particular, as CO2 levels increase in the blood collection bag, the absorbance of the absorbance dye changes, thereby changing the amount of light reaching the fluorescence layer and/or photodetector. This causes a change in emitted fluorescence that is detected.
:~' .
, .~ ~ . - . . .
. :. .. , : . ' ' r, ''' ' , " ' ~ ' ., . ' . ~
' ~ ' '' '' ' ~ ' ~
W092/l9764 PCT/US92/03637 ` 17 ` ~ 6~ i The following examples serve to illustrate the method of the present invention. The concentration of reagents and other variable parameters are only shown to exemplify the methods of the present invention and are not to be considered ~ .
limitation thereof.
Example 1 At the time a unit of blood is drawn, an additional amount (lOml) is collected in such a manner as to be subsequently sectioned off from the unit to be transfused. This additional blood is then expressed through a tube into a flexible bag, attached to the blood collection bag. This side bag is supplied containing a microorganism growth media and an attached multi-layer sensor. The sensor is capable of detecting microorganism growth by measuring an increase in CO2 production through a change in fluorescence emitted from the sensor.
After adding the additional blood to the bag containing media and the sensor, and waiting a predetermined amount of time (2 - 6 hours) for the sensor to equilibrate, an initial reading of the sensor is made using a portable handheld fluorometer ` ,to produce a baseline fluorescence level. This level can be ~anually recorded for latter comparison or a bar code can be provided and attached to the bag. The ; blood and additional monitoring bag are then stored in -~ a normal manner (4C).
~- At the time the blood is to be used for `; 30 transfusion a second reading of the sensor is made and compared to the first reading. This is compared to the original reading. If a bar code was produced, the bar code and sensor are read. The instrument will :
.
. .
.` .
.. ^. .. A ....... . . - --.
:.. ' ~ ' ' . . .
,". . ~ ' - :-. - '- ' '':. - . ;
WO92/197~ PCTIUS92/03~37 ` Z~S6~8 18 `;
compare the initial and final fluorescent values and based upon an established threshold level of change will signal negative or positive for growth. In this particular embodiment, the instrument will signal green for no growth or red for growth based on differences in original and final sensor readings.
Exam~le 2 Xylenol Blue - Rhodamine 101 Sensor Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the manufacturer. Next - 5% w/w of a 50mM xylenol blue, dissolved in 5mM borate buffer pH 11 containing 1% Tween 80, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55C for 2 hours.
Wacker silicone is prepared, as described above. Next 2~ w/w of 7.5mM Rhodamine 101, in 50mM
Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone. The mixture is poured over the previously cured xylenol blue layer in the mold, described above, and cured at 55C overnight. This cured, dehydrated, double layer sensor consists of two 25 distinct layers, each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto ~- the base of bottles using more silicone, ensuring that the absorbance layer is face down. Finally, the bottles are cured at 55C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes. Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum. The blood .:; .
,. ~ .
`., ,~
.
.
: : .
..
. .
", ' " ~'~ - . :' : .
4 PCr/US92f i)3~
2~S6~8 i 9 , ~ 3 culture bottle is placed in the instrument and fluorescence emission is measured.
As the concentration of C02 increases in the blood culture bottle, the pH sensitive absorbance dye, Xylenol blue, the absorbance of the dye decreases, thus allowing more light to reach the fluorophore, Rhodamine 101, to thus increase the amount of fluorescence emitted at 590nM. This increase in fluorescence intensity v. time is shown in the blood culture growth curve at Fig. 2.
ExamPle 3 Xvlenol Blue in Silicone/Rhodamine B in AcrYlic Rhone Poulenc silicone elastomer 141 part A
is thoroughly mixed with Rhone Poulenc 141 catalyst part B in a 10:1 ratio, as recommended by the manufacturer. Next 1% w/w of a lOOmM xylenol blue solution pH #11, dissolved in lOmM borate buffer containing 1% Tween 80, is added to the silicone and mixed thoroughly with a tongue blade to ensure uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch. The mold is allowed ; ~ to sit out on the countertop at room temperature for ; , about one hour or until the bubbles have disappeared, at which time the mold is placed in the incubator to cure at 55~C for two hours.
Rhone-Poulenc silicone is prepared, as described above. Next, a 40/1,000" thick acrylic disc (Glasflex, Inc.), approximately 1 cm in diameter, - 30 containing 0.2 grams/lb of rhodamine B (Sigma) is glued onto the above absorbance layer using the Rhone-Poulenc Silicone at the 10:1 ratio as glue. The double layer sensor is then placed back in the 55C
~' ', ~';
.,:, ... ~ .
: . - . .
:.
:
.
. . . : .. . ::
: . - :
2 ~ ~ S6 ~8 20 incubator for two hours to allow for adherence of the two layers. Following the curing, the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face dow~, using the Rhone Poulenc silicone as mentioned above. The bottle is placed in the 55C incubator to cure for at least two hours.
The bottle is then rehydrated overnite and tested the following day as described in Example 1.
As the concentration of co2 increases in the blood culture bottle, the absorbance of the pH
sensitive absorbance based dye xylenol blue decreases, thus allowing more light to reach the fluorophore (rhodamine B) doped acrylic, to thus increase the amount of fluorescence emitted at 590nm. This increase in fluorescence intensity v. time is shown in the blood culture growth curve in Fig. 3.
Example 4 XYlenol Blue in Silicone/6213 Red Standard AcrYl ic Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the ,manufacturer. Next 5% w/w of a 50mM xylenol blue, dissolv$d in 5m~ borate buffer pH 11 containing 1%
- Tween 80, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55C for two hours.
~ Next, a 40/1,000" thick acrylic disc ; (Glasflex, Inc.), approximately 1 cm in diameter, " referred to as No. 6213 Red (Glasflex Standard ,; .
:. .
. .. . . .
: . . . .
:; . :
: . . . :
-:, WO92/19764 2~S6~ PCT/US92/~3637 21 ~
Product) is glued onto the above absorbance layer using the Wacker silico~e at the 9:1 ratio as glue.
The double layer sensor is then placed back in the 55 C incubator for two hours to allow for adherence of the two layers. Following the curing, the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face down, using the Rhone Poulenc silicone as mentioned above. The bottle is placed in the 55C incubator to cure for at least two hours. The bottle is then rehydrated overnite and tested the following day as described in Example l.
As the concentration of C02 increases in the blood culture bottle, the absorbance of the pH
sensitive absorbance based dye xylenol blue decreases, thus allowing more light to reach the fluorophore (rhodamine B) doped acrylic, to thus increase the amount of fluorescence emitted at 590nm. This increase in fluorescence intensity v. time is shown in the blood culture growth curve in Fig. 4.
ExamPle 5 Bromthvmol Blue in Silicone/Rhodamine lOl in Silicone Wacker silicone elastomer 3601 part A is ,thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratlo, as recommended by the manufacturer. Next 5% w/w of 50mM bromthymol blue, dissolved in 5mM tris buffer pH 12 in ethylene glycol, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55C for two hours.
': `
:" .
:
: . :., . - , - ~ : , .. . .
; ~
WO92~197~ PCT/US~2/03637 2~6~8 22 ~
Wacker silicone ls prepared, as described above. Next 2% w/w of 7.5mM Rhodamine 101, in 50mM
Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone. The mixture is poured over the previously cured xylenol blue layer in the mold, described above to isolate the absorbance layer. This sensor is then cured at 55C overnight. This cured, dehydrated, double layer sensor consists of two distinct layers, each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto the base of bottles using more silicone, ensuring that the absorbance layer is face down. Finally, the bottles are cured at 55C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes. Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum. The blood culture bottle is placed in the instrument and fluorescence emission is measured. The increase in fiuorescence intensity v. time is shown in blood culture growth curve in Fig. 5.
- Although this invention has been described with respect to specific embodiments, the details ~thereof are not to be construed as limitations, for it ,will be apparent that various equivalents, changes and modifications may be resorted to without departing from the spirit and scope thereof and it is understood -~ that such equivalent embodiments are intended to be included herein.
. .
... .
.
. . ~
. .
' .
~ ... . .. .
:; . : ' ; . :
2~S6~8 i 9 , ~ 3 culture bottle is placed in the instrument and fluorescence emission is measured.
As the concentration of C02 increases in the blood culture bottle, the pH sensitive absorbance dye, Xylenol blue, the absorbance of the dye decreases, thus allowing more light to reach the fluorophore, Rhodamine 101, to thus increase the amount of fluorescence emitted at 590nM. This increase in fluorescence intensity v. time is shown in the blood culture growth curve at Fig. 2.
ExamPle 3 Xvlenol Blue in Silicone/Rhodamine B in AcrYlic Rhone Poulenc silicone elastomer 141 part A
is thoroughly mixed with Rhone Poulenc 141 catalyst part B in a 10:1 ratio, as recommended by the manufacturer. Next 1% w/w of a lOOmM xylenol blue solution pH #11, dissolved in lOmM borate buffer containing 1% Tween 80, is added to the silicone and mixed thoroughly with a tongue blade to ensure uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch. The mold is allowed ; ~ to sit out on the countertop at room temperature for ; , about one hour or until the bubbles have disappeared, at which time the mold is placed in the incubator to cure at 55~C for two hours.
Rhone-Poulenc silicone is prepared, as described above. Next, a 40/1,000" thick acrylic disc (Glasflex, Inc.), approximately 1 cm in diameter, - 30 containing 0.2 grams/lb of rhodamine B (Sigma) is glued onto the above absorbance layer using the Rhone-Poulenc Silicone at the 10:1 ratio as glue. The double layer sensor is then placed back in the 55C
~' ', ~';
.,:, ... ~ .
: . - . .
:.
:
.
. . . : .. . ::
: . - :
2 ~ ~ S6 ~8 20 incubator for two hours to allow for adherence of the two layers. Following the curing, the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face dow~, using the Rhone Poulenc silicone as mentioned above. The bottle is placed in the 55C incubator to cure for at least two hours.
The bottle is then rehydrated overnite and tested the following day as described in Example 1.
As the concentration of co2 increases in the blood culture bottle, the absorbance of the pH
sensitive absorbance based dye xylenol blue decreases, thus allowing more light to reach the fluorophore (rhodamine B) doped acrylic, to thus increase the amount of fluorescence emitted at 590nm. This increase in fluorescence intensity v. time is shown in the blood culture growth curve in Fig. 3.
Example 4 XYlenol Blue in Silicone/6213 Red Standard AcrYl ic Wacker silicone elastomer 3601 part A is thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended with Wacker 3601 catalyst part B in a 9:1 ratio, as recommended by the ,manufacturer. Next 5% w/w of a 50mM xylenol blue, dissolv$d in 5m~ borate buffer pH 11 containing 1%
- Tween 80, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55C for two hours.
~ Next, a 40/1,000" thick acrylic disc ; (Glasflex, Inc.), approximately 1 cm in diameter, " referred to as No. 6213 Red (Glasflex Standard ,; .
:. .
. .. . . .
: . . . .
:; . :
: . . . :
-:, WO92/19764 2~S6~ PCT/US92/~3637 21 ~
Product) is glued onto the above absorbance layer using the Wacker silico~e at the 9:1 ratio as glue.
The double layer sensor is then placed back in the 55 C incubator for two hours to allow for adherence of the two layers. Following the curing, the double layer sensor is punched out with a cork borer, and glued onto the base of a Wheaton bottle, ensuring that the absorbance layer is face down, using the Rhone Poulenc silicone as mentioned above. The bottle is placed in the 55C incubator to cure for at least two hours. The bottle is then rehydrated overnite and tested the following day as described in Example l.
As the concentration of C02 increases in the blood culture bottle, the absorbance of the pH
sensitive absorbance based dye xylenol blue decreases, thus allowing more light to reach the fluorophore (rhodamine B) doped acrylic, to thus increase the amount of fluorescence emitted at 590nm. This increase in fluorescence intensity v. time is shown in the blood culture growth curve in Fig. 4.
ExamPle 5 Bromthvmol Blue in Silicone/Rhodamine lOl in Silicone Wacker silicone elastomer 3601 part A is ,thoroughly mixed with Wacker 3601 catalyst part B in a 9:1 ratlo, as recommended by the manufacturer. Next 5% w/w of 50mM bromthymol blue, dissolved in 5mM tris buffer pH 12 in ethylene glycol, is added to the silicone and homogenized to ensure a uniform distribution of the dye. The absorbance layer mixture is then poured into an aluminum square mold to a thickness of 30/1000 of an inch and cured at 55C for two hours.
': `
:" .
:
: . :., . - , - ~ : , .. . .
; ~
WO92~197~ PCT/US~2/03637 2~6~8 22 ~
Wacker silicone ls prepared, as described above. Next 2% w/w of 7.5mM Rhodamine 101, in 50mM
Tris-HCl buffer pH 8.5 in 95% ethylene glycol, is added to the silicone. The mixture is poured over the previously cured xylenol blue layer in the mold, described above to isolate the absorbance layer. This sensor is then cured at 55C overnight. This cured, dehydrated, double layer sensor consists of two distinct layers, each 30/1000 of an inch thick. Disks may now be punched out of the mold and adhered onto the base of bottles using more silicone, ensuring that the absorbance layer is face down. Finally, the bottles are cured at 55C for 15 minutes, rehydrated with normal saline and autoclaved on the wet cycle for 17 minutes. Saline is replaced with growth media and inoculated with E. coli by injecting a suspension with a sterile needle through the septum. The blood culture bottle is placed in the instrument and fluorescence emission is measured. The increase in fiuorescence intensity v. time is shown in blood culture growth curve in Fig. 5.
- Although this invention has been described with respect to specific embodiments, the details ~thereof are not to be construed as limitations, for it ,will be apparent that various equivalents, changes and modifications may be resorted to without departing from the spirit and scope thereof and it is understood -~ that such equivalent embodiments are intended to be included herein.
. .
... .
.
. . ~
. .
' .
~ ... . .. .
:; . : ' ; . :
Claims (15)
1. A microorganism growth monitoring apparatus for collected bodily fluid to be transfused into a patient comprising:
a. a flexible bag;
b. means to add said bodily fluid to said bag;
c. a sensor for detecting microbial growth in said bag, said sensor comprising a pH
sensitive absorbance based dye encapsulated in a light transmissive, gas permeable, proton impermeable matrix, and a pH
insensitive fluorescent dye in an inert light transparent matrix, said first and second matrices being spectrally coupled, said sensor being attached to the inside wall of said bag.
a. a flexible bag;
b. means to add said bodily fluid to said bag;
c. a sensor for detecting microbial growth in said bag, said sensor comprising a pH
sensitive absorbance based dye encapsulated in a light transmissive, gas permeable, proton impermeable matrix, and a pH
insensitive fluorescent dye in an inert light transparent matrix, said first and second matrices being spectrally coupled, said sensor being attached to the inside wall of said bag.
2. The apparatus of claim 1 wherein said bag is a blood collection bag.
3. The apparatus of claim 2 wherein said bag is a sample test bag.
4. A method to detect microbial growth, in collected bodily fluid to be transfused into a patient, in a flexible bag containing a microbial growth sensor attached to the inside of said bag comprising:
a. adding said bodily fluid to said bag;
b. storing said bag at about 4°C for a sufficient period of time to allow for microbial growth;
c. detecting microbial growth to obtain a baseline reading of growth using said sensor, d. detecting microbial growth in said bag prior to transfusion to obtain reading prior to transfusion;
e. comparing said baseline reading to said reading prior to transfusion to determine if microbial growth has occurred in said bodily fluid.
a. adding said bodily fluid to said bag;
b. storing said bag at about 4°C for a sufficient period of time to allow for microbial growth;
c. detecting microbial growth to obtain a baseline reading of growth using said sensor, d. detecting microbial growth in said bag prior to transfusion to obtain reading prior to transfusion;
e. comparing said baseline reading to said reading prior to transfusion to determine if microbial growth has occurred in said bodily fluid.
5. The method of claim 4 wherein said microbial growth sensor is comprised of a pH sensitive absorbance based dye encapsulated in a light transmissive, gas permeable, proton impermeable matrix, and a pH insensitive fluorescent dye in an inert light transparent matrix, said first and second matrices being spectrally coupled.
6. The method of claim 4 wherein said microbial growth is detected by measuring an increase in CO2 production through a change in fluorescence emitted from said sensor.
7. The method of claim 6 wherein a handheld fluorometer is used to detect changes in emitted fluorescence.
8. The method of claim 4 wherein said bag is a blood collection bag.
9. The method of claim 4 wherein said bag is a sample test bag.
10. The method of claim 9 wherein said bag contains bacterial growth media.
11. The method of claim 9 wherein said bag contains an inert substance.
12. The method of claim 4 wherein said fluid is blood.
13. A noninvasive method to detect microbial growth in a flexible bag comprising:
a. adding blood to a said bag containing a sensor for CO2 production:
b. means to noninvasively monitor said sensor to determine microbial growth.
a. adding blood to a said bag containing a sensor for CO2 production:
b. means to noninvasively monitor said sensor to determine microbial growth.
14. The method of claim 13 wherein said sensor emits fluorescence light upon interrogation with a fluorometer as a function of microbial growth.
15. The method of claim 13 wherein said sensor changes color in response to microbial growth.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69708091A | 1991-05-08 | 1991-05-08 | |
| US7/697,080 | 1991-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2086608A1 true CA2086608A1 (en) | 1992-11-09 |
Family
ID=24799702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2086608 Abandoned CA2086608A1 (en) | 1991-05-08 | 1992-04-29 | Method and apparatus to detect bacterial contamination of transfusable blood |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0538450A1 (en) |
| JP (1) | JPH05508556A (en) |
| AU (1) | AU1915892A (en) |
| CA (1) | CA2086608A1 (en) |
| WO (1) | WO1992019764A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5601997A (en) | 1995-02-03 | 1997-02-11 | Tchao; Ruy | Chemotaxis assay procedure |
| US5843699A (en) * | 1997-04-08 | 1998-12-01 | Difco Laboratories, Inc. | Rapid microorganism detection method |
| GB2339903A (en) * | 1998-07-23 | 2000-02-09 | Fsm Technologies Ltd | Fluid container |
| EP1122535A3 (en) * | 2000-01-31 | 2004-09-22 | The Penn State Research Foundation | Interrogation of changes in the contents of a sealed container |
| US20040058453A1 (en) * | 2002-09-20 | 2004-03-25 | 3M Innovative Properties Company | Reaction pouch comprising an analytical sensor |
| DE102007013736B4 (en) * | 2007-03-22 | 2011-05-12 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Method for detecting bacteria in blood-derived samples by oxygen concentration determination |
| EP2635700B1 (en) * | 2010-11-01 | 2018-02-28 | 3M Innovative Properties Company | Biological sterilization indicator |
| US20140170699A1 (en) * | 2011-05-12 | 2014-06-19 | Abbott Laboratories | Test for detecting spoilage in a flexible packet |
| GB201120991D0 (en) | 2011-12-07 | 2012-01-18 | Univ Manchester | Microsensor |
| WO2014012584A1 (en) * | 2012-07-18 | 2014-01-23 | Siemens Aktiengesellschaft | Analysis device for examining a fluid in a flexible sac and reaction container having a wall made of a flexible material |
| JP2016518152A (en) * | 2013-03-13 | 2016-06-23 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Chemochromic medical device |
| JP6020513B2 (en) | 2014-05-29 | 2016-11-02 | 横河電機株式会社 | Cell culture bag and method for producing cell culture bag |
| US10907126B2 (en) | 2016-03-01 | 2021-02-02 | Asp Global Manufacturing Gmbh | Self-contained biological indicator |
| US11242505B2 (en) | 2017-01-03 | 2022-02-08 | Asp Global Manufacturing Gmbh | Self-contained biological indicator |
| US11053534B2 (en) | 2017-06-30 | 2021-07-06 | Asp Global Manufacturing Gmbh | Systems and methods for confirming activation of biological indicators |
| US11248250B2 (en) | 2017-12-01 | 2022-02-15 | Asp Global Manufacturing Gmb | Self-contained biological indicator |
| CN113125656B (en) * | 2020-01-16 | 2023-07-04 | 中国农业科学院农业信息研究所 | Intelligent fruit bag for monitoring fruit growth |
| AU2021376932A1 (en) | 2020-11-10 | 2023-06-22 | Advanced Sterilization Products, Inc. | Ampoule breaker for a biological indicator |
| CN115327111A (en) * | 2022-07-29 | 2022-11-11 | 厦门宝太生物科技股份有限公司 | Immunochromatography test strip with variable color indication and use method thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3676679A (en) * | 1970-04-22 | 1972-07-11 | Johnston Lab Inc | Apparatus for detecting biological activity |
| US4073691A (en) * | 1976-08-24 | 1978-02-14 | Johnston Laboratories, Inc. | Method for detecting the presence of biologically active agents |
| US4182656A (en) * | 1976-09-10 | 1980-01-08 | Johnston Laboratories, Inc. | Method for detecting the presence of biologically active agents utilizing 13 C-labeled substrates |
| US4152213A (en) * | 1977-03-10 | 1979-05-01 | Johnston Laboratories, Inc. | Vacuum detection of bacteria |
| GB1601689A (en) * | 1977-07-15 | 1981-11-04 | Mariel C | Method of diagnosing bacteremia and apparatus therefor |
| DE3026089A1 (en) * | 1980-07-10 | 1982-06-09 | Hans Günter Priv.Doz. Dr.med. 6900 Heidelberg Nöller | FLASH PHOTOMETER FOR NEPHELOMETRIC AND FLUOROMETRIC APPLICATIONS |
| DE3380263D1 (en) * | 1982-04-14 | 1989-08-31 | Radiometer Corporate Dev Limit | Microbiological test processes and apparatus |
| ZA834672B (en) * | 1982-08-31 | 1984-03-28 | Becton Dickinson Co | Detection of the presence of biological activity utilizing infrared analysis |
| US4557900A (en) * | 1982-09-28 | 1985-12-10 | Cardiovascular Devices, Inc. | Optical sensor with beads |
| AT379688B (en) * | 1982-11-22 | 1986-02-10 | List Hans | SENSOR ELEMENT FOR DETERMINING THE O2 CONTENT OF A SAMPLE |
| AT377095B (en) * | 1982-11-23 | 1985-02-11 | List Hans | SENSOR ELEMENT FOR DETERMINING THE O2 CONTENT OF A SAMPLE AND METHOD FOR PRODUCING THE SAME |
| AT380957B (en) * | 1982-12-06 | 1986-08-11 | List Hans | SENSOR ELEMENT FOR FLUORESCENT OPTICAL MEASUREMENTS, AND METHOD FOR THE PRODUCTION THEREOF |
| CA1261717A (en) * | 1982-12-23 | 1989-09-26 | John R. Bacon | Method and apparatus for oxygen determination |
| GB8303096D0 (en) * | 1983-02-04 | 1983-03-09 | Oxoid Ltd | Bacterial testing |
| US4495293A (en) * | 1983-02-24 | 1985-01-22 | Abbott Laboratories | Fluorometric assay |
| SE439927B (en) * | 1984-02-10 | 1985-07-08 | Sangtec Medical Ab | DEVICE AND PROCEDURE FOR REGISTRATION OF BACTERIAL EVENTS, SPECIFICALLY UNDER FIELD CONDITIONS |
| GB8416044D0 (en) * | 1984-06-22 | 1984-07-25 | Unilever Plc | Carrying out microchemical and microbiological tests |
| GB8416045D0 (en) * | 1984-06-22 | 1984-07-25 | Unilever Plc | Carrying out microchemical and microbiological tests |
| JPS61186854A (en) * | 1985-02-14 | 1986-08-20 | Fuji Photo Film Co Ltd | Instrument for measuring number of bacteria in ultra-pure water |
| US4653907A (en) * | 1985-06-11 | 1987-03-31 | Freundlich Lawrence F | Blood culture bottle examining instrument |
| US4824789B1 (en) * | 1986-10-10 | 1996-08-13 | Minnesota Mining & Mfg | Gas sensor |
| US4867919A (en) * | 1986-10-10 | 1989-09-19 | Minnesota Mining And Manufacturing Company | Method of making a gas sensor |
| US4772558A (en) * | 1987-06-01 | 1988-09-20 | Ranier Hammann | Blood culture system |
| US4780191A (en) * | 1987-06-26 | 1988-10-25 | Massachusetts Institute Of Technology | L-glutamine sensor |
| US5094955A (en) * | 1988-03-15 | 1992-03-10 | Akzo N.V. | Device and method for detecting microorganisms |
| US4945060A (en) * | 1988-03-15 | 1990-07-31 | Akzo N. V. | Device for detecting microorganisms |
-
1992
- 1992-04-29 EP EP92911615A patent/EP0538450A1/en not_active Withdrawn
- 1992-04-29 AU AU19158/92A patent/AU1915892A/en not_active Abandoned
- 1992-04-29 WO PCT/US1992/003637 patent/WO1992019764A1/en not_active Application Discontinuation
- 1992-04-29 CA CA 2086608 patent/CA2086608A1/en not_active Abandoned
- 1992-04-29 JP JP92511486A patent/JPH05508556A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0538450A1 (en) | 1993-04-28 |
| EP0538450A4 (en) | 1994-04-06 |
| JPH05508556A (en) | 1993-12-02 |
| WO1992019764A1 (en) | 1992-11-12 |
| AU1915892A (en) | 1992-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2086608A1 (en) | Method and apparatus to detect bacterial contamination of transfusable blood | |
| US5164301A (en) | Process and kit for detecting microbial metabolism | |
| EP0333253B1 (en) | Apparatus and device for detecting microorganisms | |
| US5372784A (en) | Measurement of bacterial CO2 production in an isolated fluorophore by monitoring an absorbance regulated change of fluorescence | |
| Kuswandi et al. | Optical fibre biosensors based on immobilised enzymes | |
| EP0507930B1 (en) | Measurement of color reactions by monitoring a change of fluorescence | |
| JP3043063B2 (en) | Precipitation test for microorganisms | |
| EP0446972B1 (en) | Device and methods for detecting microorganisms | |
| US5856175A (en) | Device for detecting microorganisms | |
| US7745169B2 (en) | Device and method for the detection and enumeration of multiple groups of microorganisms | |
| JP4404555B2 (en) | Sensor formulation for detecting a gas composition and method of manufacturing the same | |
| MXPA05003068A (en) | Detection of biological molecules by differential partitioning of enzyme substrates and products. | |
| FI96434B (en) | Apparatus for amplifying fluorescence and kinetics and methods of using the apparatus | |
| Bullock et al. | Biochemical profile-based microbial identification systems | |
| AU652423B2 (en) | Measurement of bacterial CO2 production in an isolated fluorophore by monitoring an absorbance regulated change of fluorescence | |
| US8535937B2 (en) | Detection of microorganisms with a fluorescence-based device | |
| EP2252700B1 (en) | Method for real-time detection of microorganisms in a liquid culture medium using cellular lysis | |
| US20240175819A1 (en) | Diagnostic test | |
| US20200248226A1 (en) | Method and device for the detection of carbapenemases and carbapenemase producers | |
| JP2015504684A (en) | In vitro detection of microorganisms by azoreductase activity | |
| INTACT | ANTIBODIES FOR SALICYLATE AND THEIR PREPARATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |